Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial.
Eur J Cancer
; 164: 30-38, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35151105
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Cerebellar Neoplasms
/
Medulloblastoma
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Eur J Cancer
Year:
2022
Document type:
Article
Country of publication: